BWS Financial maintains Sell rating on Twist Bioscience
BWS Financial maintained a Sell rating on Twist Bioscience and reiterated a $45.00 price target, implying 71.1% downside versus the Sep 17 close of $155.56.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.